Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/2012
06/07/2012US20120141372 RS7 Antibodies
06/07/2012US20120141371 Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
06/07/2012CA2821515A1 Anti-ngf compositions and use thereof
06/07/2012CA2821067A1 Neoantibodies for diagnosing tissue injury
06/07/2012CA2820622A1 Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof
06/07/2012CA2819679A1 Compositions and methods for treating amyloid plaque associated symptoms
06/07/2012CA2819530A1 Cytotoxicity-inducing therapeutic agent
06/07/2012CA2819520A1 Tolerance induction or immunosupression to prevent in particular graft-versus-host-disease (gvhd) by short-term pre-incubation of transplanted cell suspensions, tissues or organs coated with ligands to cell surface molecules
06/07/2012CA2819504A1 Anti-bradykinin b2 receptor (bkb2r) monoclonal antibody
06/07/2012CA2819463A1 Tomm34 peptides and vaccines including the same
06/07/2012CA2819356A1 Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly
06/07/2012CA2819187A1 Covalently dimerized bivalent binding agents
06/07/2012CA2819070A1 Means and methods for producing high affinity antibodies
06/07/2012CA2818992A1 Chimeric rabbit/human ror1 antibodies
06/07/2012CA2818173A1 Low affinity blood brain barrier receptor antibodies and uses therefor
06/07/2012CA2814962A1 In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
06/06/2012EP2460832A2 TWEAK binding antibodies
06/06/2012EP2460831A2 Tweak binding antibodies
06/06/2012EP2460830A2 IL-18 binding proteins
06/06/2012EP2460829A2 IL-18 binding proteins
06/06/2012EP2460828A2 Antibodies and diagnostics
06/06/2012EP2460538A1 Cancer metastasis inhibitor
06/06/2012EP2460537A1 Methods for treating conditions associated with MASP-2 dependent complement activation
06/06/2012EP2459729A2 Dual variable domain immunoglobulins and uses thereof
06/06/2012EP2459708A1 H. pylori lipopolysaccharide outer core epitope
06/06/2012EP2459595A1 Muc1 antibodies
06/06/2012EP2459594A1 Fully human antibodies to btla
06/06/2012EP2459593A2 Anti-tgf-beta receptor type ii single domain antibodies
06/06/2012EP2459592A1 High affinity human antibodies to human angiopoietin-2
06/06/2012EP2459591A1 Inhibition of tumor metastasis using bv8- or g-csf-antagonists
06/06/2012EP2459590A1 Enzymatic antibody processing
06/06/2012EP2459588A1 Method for detecting and identifying a variant c. difficile strain in a sample
06/06/2012EP2459215A1 Method and kit for treating nicotine addiction
06/06/2012EP2459213A1 Polypeptides that bind tissue inhibitor of metalloproteinase type three (timp-3), compositions and methods
06/06/2012EP2459167A2 Subcutaneous anti-her2 antibody formulation
06/06/2012EP2261374B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having Class I membrane fusogenic envelope proteins
06/06/2012EP2115003B1 Human antibodies to human delta like ligand 4
06/06/2012EP2061814B1 Antibodies and immunoconjugates and uses therefor
06/06/2012EP2004693B1 Compositions and methods of use for antibodies of c-met
06/06/2012EP1851250B1 Human monoclonal antibody to prostate specific membrane antigen (psma)
06/06/2012EP1846767B1 Kid31 and antibodies that bind thereto
06/06/2012EP1628530B1 Methods and compositions for the prevention and treatment of sepsis
06/06/2012EP1616575B1 Method for treating inflammation
06/06/2012EP1568775B1 Cancer-associated gene
06/06/2012CN1922207B A method of providing a purified, virus safe antibody preparation
06/06/2012CN1641353B Analyzing and typing monoclonal proteins by capillary electrophoresis and immunodisplacement
06/06/2012CN102485753A Human derived heavy chain variable region possessing human vascular endothelial growth factor binding activity
06/06/2012CN101935675B Construction and application of cell membrane expression ALV-env fluorescin eukaryotic transgenic expression plasmid
06/06/2012CN101845094B Double-cross-linking chemical synthesis method of citrinin-protein-coupled antigen and preparation method of anti-citrinin monoclonal antibody
06/06/2012CN101831407B Hybridoma cell line of monoclonal antibody against African swine fever virus and secreted monoclonal antibody thereof
06/06/2012CN101690812B Concentrated freeze-dried yolk antibody composite preparation for Newcastle disease-infectious bursal disease and preparation process thereof
06/06/2012CN101671392B Monoclonal antibody resisting hemocyanin of China prawns as well as preparation method and application thereof
06/06/2012CN101446585B Reagent for detecting tubercle bacillus infection in vitro and method thereof
06/06/2012CN101407458B I type pyrethroid universal hapten compound and synthetic method thereof
06/05/2012US8194229 Dynamic fluid control system for immersion lithography
06/05/2012US8193414 Polypeptides; antisense nucleic acids; gene expression vectors that have been inserted: transgenic plants; agriculture; diagnosis; screening; therapy
06/05/2012US8193326 Nucleotide sequences coding oncogenic polypeptides for use in generating vaccines to prevent and treat cell proliferative disorders; genetic vaccines
06/05/2012US8193322 Methods for generating monovalent IgG
06/05/2012US8193321 Multispecific antibodies
06/05/2012US8193320 Antibodies to NTB-A
06/05/2012US8193319 Antibodies to IL-17A
06/05/2012US8193318 FcγRIIB specific antibodies and methods of use thereof
06/05/2012US8193162 Human liver regeneration associated protein and the use thereof
06/05/2012US8192953 Comprising tetranectin trimerising structural element (TTSE) capable of forming a stable complex with two other TTSEs; stability; used as a carrier of other chemical entities; drug delivery
06/05/2012US8192927 Human bind molecules capable of neutralizing influenza virus h5n1 and uses thereof
06/05/2012US8192740 Pharmaceutical composition comprising anti-GRP78 antibody as active ingredient
06/05/2012US8192739 Fusion proteins containing recombinant cytotoxic RNAses
06/05/2012US8192738 Targeted antibodies directed to DLL4
06/05/2012US8192737 Identification and engineering of antibodies with variant Fc regions and methods of using same
06/05/2012US8192736 Remedy for endometriosis
06/05/2012US8192735 Method for modulating appetite
06/05/2012CA2561826C Linear single chain recombinant anti-cea/cd3/cd28 trispecific antibody
06/05/2012CA2519787C Methods of treating diabetes by blocking vegf-mediated activity
06/05/2012CA2519113C Antibodies against insulin-like growth factor i receptor and uses thereof
06/05/2012CA2435375C Mammalian tumor susceptibility gene products and their uses
06/05/2012CA2368670C Modulation of vascular permeability by means of tie2 receptor activators
06/05/2012CA2366455C Immunoadsorber for use in sepsis therapy
06/05/2012CA2264939C Materials and methods relating to the diagnosis and treatment of pre-eclampsia and diabetes
06/05/2012CA2249352C Immunoliposomes that optimize internalization into target cells
06/05/2012CA2187546C Rps2 gene and uses thereof
06/05/2012CA1341630C Transformation vectors allowing expression of foreign polypeptide endotoxins in plants
05/2012
05/31/2012WO2012071216A2 Antibodies for tumor gangliosides
05/31/2012WO2012070970A1 Diagnostic method for predicting the development of cancerous diseases and monitoring treatment efficacy
05/31/2012WO2012070969A1 Diagnostic method for predicting the development of cardiovascular diseases and monitoring treatment efficacy
05/31/2012WO2012069571A1 In vitro method for determining presence of type ii pyrethroids
05/31/2012WO2012069557A1 Multispecific antigen binding proteins targeting hgf
05/31/2012WO2012069550A1 Novel homogeneous humanized antiproliferation antibodies
05/31/2012WO2012069466A1 Multispecific molecules
05/31/2012WO2012069433A2 Antigen binding proteins
05/31/2012WO2012068637A1 Compositions and methods
05/31/2012WO2012047317A3 Tumor specific antibodies and uses therefor
05/31/2012WO2012045882A3 Phosphospecific antibodies recognising tau
05/31/2012WO2012034025A3 Human cytomegalovirus vaccine
05/31/2012WO2012030904A3 Human immunodeficiency virus (hiv)-neutralizing antibodies
05/31/2012WO2012027328A3 Anti-ox40 antibodies and methods of using the same
05/31/2012WO2012026878A8 Monoclonal antibody specific to major neutralizing epitope of influenza h5 hemagglutinin
05/31/2012WO2012024650A3 Anti-ngf antibodies and their use
05/31/2012WO2012018790A3 Dual variable domain immunoglobulins and uses thereof
05/31/2012WO2011157447A3 Modified parvovirus having enhanced anti-tumour efficacy
05/31/2012WO2011146891A3 High-affinity fully functional soluble single-domain human cd4, antibodies, and related fusion proteins
1 ... 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 ... 1494